[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100618288":3},{"organization":4,"armGroups":7,"interventions":34,"overallOfficials":10,"centralContacts":40,"locations":49,"responsibleParty":71,"collaborators":10,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":10,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":82,"enrollmentInfo":83,"targetDuration":10,"studyType":86,"phases":10,"briefSummary":87,"conditions":88,"keywords":10,"overallStatus":52,"whyStopped":10,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Qbtech AB","INDUSTRY",[8,14,18,22,26,30],{"label":9,"type":10,"description":11,"interventionNames":12},"ASD",null,"Eligible participants being referred for their initial assessment or have a diagnosis of ASD but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.",[13],"Device: Digital software application for cognitive performance and activity measurement (QbMobile, investigational device)",{"label":15,"type":10,"description":16,"interventionNames":17},"Bipolar disorder","Eligible participants being referred for their initial assessment or have a diagnosis of Bipolar Disorder but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"MDD","Eligible participants being referred for their initial assessment or have a diagnosis of MDD but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Separation Anxiety Disorder","Eligible participants being referred for their initial assessment or have a diagnosis of Separation Anxiety Disorder but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.",[13],{"label":27,"type":10,"description":28,"interventionNames":29},"Social Anxiety Disorder","Eligible participants being referred for their initial assessment or have a diagnosis of Social Anxiety Disorder but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.",[13],{"label":31,"type":10,"description":32,"interventionNames":33},"Generalized Anxiety Disorder","Eligible participants being referred for their initial assessment or have a diagnosis of Generalized Anxiety Disorder but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.",[13],[35],{"type":36,"name":37,"description":38,"armGroupLabels":39,"otherNames":10},"DEVICE","Digital software application for cognitive performance and activity measurement (QbMobile, investigational device)","Participants will complete two non-invasive, 10-minute digital tests using the QbMobile Investigational Device-one at the clinic and one at home the following day. The tests objectively measure cognitive performance and activity levels and will not influence clinical diagnosis or treatment in this study.",[9,15,31,19,23,27],[41,46],{"name":42,"role":43,"phone":44,"phoneExt":10,"email":45},"Robert Nolen","CONTACT","18325370300","robert.nolen@qbtech.com",{"name":47,"role":43,"phone":10,"phoneExt":10,"email":48},"Ragini Sanyal","ragini.sanyal@qbtech.com",[50],{"facility":51,"status":52,"city":53,"state":54,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":64},"CCM Clinical Research Group","RECRUITING","Miami","Florida","33133","United States","US",{"type":59,"coordinates":60},"Point",[61,62],-80.19366,25.77427,{"lat":62,"lon":61},[65,68],{"name":51,"role":43,"phone":66,"phoneExt":10,"email":67},"305-285-0705","contact@ccmclinicalresearch.com",{"name":69,"role":70,"phone":10,"phoneExt":10,"email":10},"Francisco Ricart, MD","PRINCIPAL_INVESTIGATOR",{"type":72,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100618288","an-examination-of-the-performance-of-qbmobile-in-differential-diagnosis-associated-with-adhd-symptoms-100618288",false,"NCT07329673","An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms","An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms.","Inclusion Criteria:\n\n* Provide written informed consent (including parent\u002Flegal guardians consent when this is required for individuals under 18 years old and assent as is required based on the age of participant) for QbMobile;\n* Aged \\> 6 years and \\\u003C 60 years old;\n* Referred for an initial assessment for ASD, MDD, Bipolar Disorder or Anxiety Disorder (Separation Anxiety Disorder, Social Anxiety Disorder, Generalized Anxiety Disorder (GAD)) or has a prior diagnosis of one of the included disorders but is not currently receiving treatment;\n* Meets DSM-5 or ICD-11 criteria for a primary diagnosis of ASD, MDD, Bipolar Disorder or Anxiety Disorder per sites standard clinical procedures;\n* Have adequate sensory and physical ability to complete QbMobile;\n* Possess or have access to an iPhone model that supports QbMobile.\n\nExclusion Criteria:\n\n* Intellectual disability designated by IQ\\\u003C70;\n* Has a DSM-5 or ICD-11 diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, psychotic disorder due to another medical condition, PTSD, antisocial personality disorder, or borderline personality disorder;\n* Has a primary diagnosis of ADHD (combined, inattentive, or hyperactivity\u002Fimpulsive presentation);\n* Has a concurrent medical diagnosis that could significantly affect test performance such as brain injuries, Parkinson's disease, current epilepsy or active seizures, amyotrophic lateral sclerosis (ALS), multiple sclerosis, dementias (e.g. vascular dementia, Alzheimer disease, etc);\n* Has other conditions that could affect test performance (migraine or other types of severe headache, chronic or acute pain);\n* Use of prescription medications (e.g., anxiolytics, sedative medications) taken on the day before completing QbMobile that could significantly affect performance;\n* Substance use (e.g., alcohol, drugs) that may affect performance on the day of the tests.","ALL","6 Years","60 Years",{"count":84,"type":85},300,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to evaluate QbMobile's ability to collect objective data to identify specific symptom profiles in differential diagnoses (ASD, MDD, Bipolar Disorder and Anxiety Disorder) that are common with ADHD.",[89,90,91,23,27,92],"Bi-Polar Disorder","Autism Spectrum Disorder (ASD)","Major Depression Disorders","Generalized Anxiety Disorder (GAD)","2026-05-04",{"date":95,"type":96},"2026-05-06","ACTUAL",{"date":98,"type":96},"2026-01-01",{"date":100,"type":85},"2026-11",{"name":5,"class":6},1]